Day: June 26, 2025

Hamilton, Bermuda, June 26, 2025 – Golar LNG Limited (the “Company”) (NASDAQ: GLNG) announces today the pricing of $500 million aggregate principal amount of its 2.75% Convertible Senior Notes due 2030 (the “Notes”), in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The Company has also granted the initial purchasers of the Notes a 30-day option to purchase up to an additional $75 million aggregate principal amount of the Notes in connection with the offering. The offering is expected to close on June 30, 2025, subject to the satisfaction of certain customary closing conditions. The Notes will be senior, unsecured obligations of the Company, bear interest at a rate of 2.75% per annum, payable semi-annually in arrears on June 15 and December...

Aryna Sabalenka becomes first-ever current athlete shareholder in Prenetics, listed on the NASDAQ: (PRE)In just six months, IM8 is one of the fastest growing supplement brands in the world, generating an extraordinary US$50m+ Annual Recurring RevenueIM8 has built a loyal customer base of 60,000+ users who have consumed over 5 million servingsIM8, co-founded by David Beckham is available at www.im8health.comCHARLOTTE, N.C., June 26, 2025 (GLOBE NEWSWIRE) — Prenetics Global Limited (NASDAQ: PRE), a leading consumer health sciences company, announced today at a special event at Wimbledon House that IM8, its premium supplements brand co-founded by David Beckham, has partnered with world No. 1 tennis star Aryna Sabalenka as its newest global ambassador and shareholder. The announcement comes just days before the start of Wimbledon...

HighlightsCredit facility secured from AFG Bank Cameroon (~US$140M), together with proceeds from the recent option exercise by Eagle Eye Asset Holdings Pte Ltd (EEA) (A$15.8M), has paved the way for the purchase of long lead items and appointment of key contractors Canyon in a strong position to commence production at the flagship Minim Martap Bauxite Project in early 2026 and make first bauxite shipment in 1H 2026 Locomotives order has been placed with CRRC Ziyang Co. Ltd (CRRC), with first deliveries scheduled for Q1 2026 Groundbreaking for the Inland Rail Facility (IRF) scheduled to commence in July 2025 Road construction contractor appointed with the haulage road upgrade works planned to commence in July 2025 Both the Mining Contractor and Ore Haulage contractor have been appointed and scheduled to mobilise to Minim Martap by end...

REYKJAVIK, ICELAND (June 26, 2025) — Alvotech (NASDAQ: ALVO, ALVO SDB, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its lenders under the Company’s existing senior secured term loan facility, including GoldenTree Asset Management (collectively, the “Lenders”), have agreed to reduce the rate of interest on its existing senior secured term loan facility (the “Facility”). The agreement will lower Alvotech’s interest payments in the first 12 months by an estimated US$8.2 million. This is an outcome of Alvotech’s sustained operational improvements and strengthened financial performance over the past year. “Since last year, we have shown significant revenue growth, operating profits and positive adjusted EBITDA, and we expect to be...

REYKJAVIK, Iceland, June 26, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its lenders under the Company’s existing senior secured term loan facility, including GoldenTree Asset Management (collectively, the “Lenders”), have agreed to reduce the rate of interest on its existing senior secured term loan facility (the “Facility”). The agreement will lower Alvotech’s interest payments in the first 12 months by an estimated US$8.2 million. This is an outcome of Alvotech’s sustained operational improvements and strengthened financial performance over the past year. “Since last year, we have shown significant revenue growth, operating profits and positive adjusted EBITDA, and...

Nokia CorporationStock Exchange Release26 June 2025 at 10:00 EEST Chief People Officer, Lorna Gibb to leave Nokia Espoo, Finland – Nokia today announces that its Chief People Officer, Lorna Gibb, has decided to leave the company and step down from its Group Leadership Team to pursue another opportunity, effective today. A recruitment process has begun for her successor. Lorna joined Nokia in 2020 and has been the Chief People Officer and a member of the Group Leadership Team since June 2024. She has been responsible for evolving Nokia’s people strategy and driving forward our talent and leadership programs. Esa Niinimäki, Chief Legal Officer, will assume Lorna’s responsibilities in the interim period as the search commences. About NokiaAt Nokia, we create technology that helps the world act together. As a B2B technology innovation leader,...

NB_Kalmar ServicesKalmar launches Inspector – a new digital application to streamline daily equipment inspections.KALMAR CORPORATION, TRADE PRESS RELEASE, 26 JUNE 2025 AT 10:00 AM (EEST) Kalmar launches Inspector – a new digital application to streamline daily equipment inspections Kalmar has announced the launch of Inspector, a digital inspection application to streamline routine inspections of material-handling equipment. Inspector, part of the MyKalmar ecosystem, makes equipment inspections more efficient and allows inspection data to be stored centrally for analysis and reporting purposes. The application is available as both a standalone mobile app and as an optional module for customers with a valid MyKalmar INSIGHT subscription. Timely, regular inspections of material handling equipment are critical to ensuring safety,...

ALK (ALKB:DC / OMX: ALK B) today announced the first market launch of EURneffy® 2 mg (the trade name for neffy® in the EU) in Germany. The launch of this first ever adrenaline nasal spray for timely emergency treatment of anaphylaxis represents a significant milestone for adults and children (≥30 kg) experiencing potentially life-threatening allergic reactions. With an intuitive, needle-free design, EURneffy® can help more people confidently use adrenaline when it matters most, supporting fast, reliable emergency treatment and ultimately helping improve the chances of successful outcomes and save lives. EURneffy® offers a longer shelf life (30 months) and superior temperature stability compared to existing adrenaline auto-injectors (AAIs). ALK’s Senior Vice President of Commercial Operations in Europe, Flora Beiche-Scholz, said:...

Tryg will conduct pre-close analyst calls and meetings starting on 26 June, ahead of the Q2 2025 results, which will be released on 11 July. This newsletter aims to inform capital market participants of the key factors influencing the company’s recent financial performance. Insurance revenue growth Tryg maintains a balanced distribution of insurance revenue across the Scandinavian countries, with approximately 50% of revenue generated in Denmark, 30% in Sweden, and 20% in Norway. In Q2 2024, Tryg reported insurance revenue of DKK 9,545m. The commercial segment will experience a smaller spillover effect into 2025 of the derisking of the corporate portfolio carried out in 2024. In general, the group revenue development remains in line with recent development. Tryg reported a growth measured in local currencies of 3.7% in Q1 2025. When...

Date: 26 June 2025 Release: Before opening of Euronext Please open the following link to read the full report including annexes:AttachmentFULL PRESS RELEASE